MTOR and colorectal carcinoma: Taken together, these findings indicate that inhibition of the mTOR/S6/4EBP1 pathway in CRC cell lines is only partially mediated by mitochondrial depolarisation and AMPK activation, and suggest that the cellular effects induced by metformin could be at least partially due to the mTOR-mediated reduction in protein synthesis.